You are on Trendlyne United States. Click here to go to India website or make United States as your default

Scienture Holdings Inc. XNAS: SCNX

Scienture Holdings Inc. Live Share Price Today, Share Analysis and Chart

0.84 -0.03 (-3.45%)

96.47% Fall from 52W High

92,473 XNAS Volume

XNAS 21 Apr, 2025 5:30 PM (EDT)

Board Meeting
The board meeting for Scienture Holdings Inc. is scheduled for today, for the purpose of Trxade Health Inc Annual Report for 2024 See details

Scienture Holdings Inc. Key Metrics

Default
All financials are in USD Million and price data in USD
VIEW MORE
Not Eligible
-
Affordable Valuation
63.8 / 100
Technically Bearish
23.1 / 100

Scienture Holdings Inc. Live Price Chart

Switch to TradingView
Created with Highcharts 9.0.1Chart context menu13. May10. Jun8. Jul5. Aug2. Sep30. Sep28. Oct25. Nov23. Dec20. Jan17. Feb17. Mar14. Apr201020122014201620182020202220240102030080MZoom1D1W1M3M1Y5YAllApr 21, 2024Apr 21, 2025trendlyne.com

Scienture Holdings Inc. Stock Analysis

Scienture Holdings Inc. stock analysis with key metrics, changes, and trends.

Scienture Holdings Inc. MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$0.14 M89.98%negative

Annual Revenue fell 89.98%, in the last year to $0.14 M. Its sector's average revenue growth for the last fiscal year was 1.09%.

Annual Net Profit$9.07 M150.81%positive

Annual Net Profit rose 150.81% in the last year to $9.07 M. Its sector's average net profit growth for the last fiscal year was -17.35%.

Price to Earning Ratio0.83-positive

Price to Earning Ratio is 0.83, lower than its sector PE ratio of 29.66.

Stock Price$0.84-86.94%negative

Stock Price fell 86.94% and underperformed its sector by 100.3% in the past year.

Quarterly Revenue$0.05 M58.74%negative

Quarterly Revenue fell 58.74% YoY to $0.05 M. Its sector's average revenue growth YoY for the quarter was 3.41%.

Quarterly Net profit$7.16 M38.6%positive

Quarterly Net profit rose 38.6% YoY to $7.16 M. Its sector's average net profit growth YoY for the quarter was -51.46%.

Debt to Equity Ratio0.04-positive

Debt to Equity Ratio of 0.04 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)22.77 %22.77%positive

Return on Equity(ROE) for the last financial year was 22.77%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

Mutual Fund Holding0.69 %-0.01%negative

Mutual Fund Holding decreased by 0.01% in the last quarter to 0.69.

Interest Coverage Ratio-13.06-negative

Interest Coverage Ratio is -13.06, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding1.05 %0%neutral

Institutional Holding remained the same in the last quarter at 1.05%.

VIEW LESS


Loading data..

Scienture Holdings Inc. - Company Profile

What does Scienture Holdings Inc. do?

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

Scienture Holdings Inc. Management structure

All Gross Remunerations are in USD
Mr. Prashant Patel
President and Chief Operating Officer
-
2025
Gross Remuneration
Year
Mr. Eric Sherb
Chief Financial Officer
-
2025
Gross Remuneration
Year

Scienture Holdings Inc. Board of directors

All Gross Remunerations are in USD
Dr. Narasimhan Mani, PhD
Director
-
2025
Gross Remuneration
Year

Scienture Holdings Inc. FAQ

How is Scienture Holdings Inc. today?
Scienture Holdings Inc. today is trading in the red, and is down by -3.45% at 0.84.
Scienture Holdings Inc. is currently trading down -3.45% on an intraday basis. In the past week the stock fell -4.55%. stock has been down -81.33% in the past quarter and fell -86.94% in the past year. You can view this in the overview section.